Mast Therapeutics, Inc.
(NYSE Amex Equities : MSTX)

( )
MSTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading MSTX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.00%163.061.3%$781.81m
GILDGilead Sciences, Inc.
0.24%67.261.0%$568.09m
CELGCelgene Corporation
-0.27%124.091.1%$481.61m
BIIBBiogen Inc.
-2.04%268.531.3%$446.03m
REGNRegeneron Pharmaceuticals, Inc.
3.03%394.142.1%$385.16m
INCYIncyte Corporation
-0.14%139.284.3%$353.74m
VRTXVertex Pharmaceuticals Incorporated
20.45%108.012.0%$218.70m
KITEKite Pharma, Inc.
-0.13%78.5117.5%$216.08m
ALXNAlexion Pharmaceuticals, Inc.
1.85%120.721.6%$208.60m
TSROTESARO, Inc.
-1.95%151.8815.6%$193.33m
ILMNIllumina, Inc.
1.08%172.663.4%$164.78m
ESPREsperion Therapeutics, Inc.
-2.44%34.7917.7%$146.82m
CLVSClovis Oncology, Inc.
-3.98%64.3917.2%$135.52m
AUPHAurinia Pharmaceuticals Inc.
1.96%7.308.0%$134.79m
EXELExelixis, Inc.
-0.71%21.135.7%$98.01m

Company Profile

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.